Ambrx Biopharma Inc. American Depositary Shares (each representing seven) Made Headway
Thu, Feb 23, 2023 at 07:12 PM
Ambrx Biopharma Inc. American Depositary Shares (each representing seven) (AMAM:NYSE) rocketted at $6.53, a gain of 43.2%. On Thu, Feb 23, 2023, AMAM:NYSE hit a New 2-Week High of $6.53. The stock appeared on our News Catalysts scanner on Thu, Feb 16, 2023 at 08:03 AM in the 'BIOTECH' category. From Thu, Feb 09, 2023, the stock recorded 77.78% Up Days and 80.00% Green Days
About Ambrx Biopharma Inc. American Depositary Shares (each representing seven) (AMAM:NYSE)
Ambrx Biopharma Inc is a clinical-stage biologics company focused on discovering and developing a novel class of engineered precision biologics (EPBs) using its proprietary expanded genetic code...
Top 10 Gainers:
- Ocean Biomedical Inc Com (OCEA:NASDAQ), 124.53%
- Genesis Growth Tech Acquisition Corp. (GGAA:NASDAQ), 63.94%
- Atlas Lithium Corporation (ATLX:NASDAQ), 60.47%
- Ambrx Biopharma Inc. American Depositary Shares (each representing seven) (AMAM:NYSE), 43.2%
- Expion360 Inc. (XPON:NASDAQ), 42.39%
- Applied Molecular Transport Inc. (AMTI:NASDAQ), 34.69%
- Sigilon Therapeutics Inc. (SGTX:NASDAQ), 32.91%
- Vascular Biogenics Ltd. (VBLT:NASDAQ), 29.46%
- Verde Clean Fuels Cl A (VGAS:NASDAQ), 28.15%
- Elevation Oncology Inc. (ELEV:NASDAQ), 27.27%